Form 4: iRhythm CTO Granted 6,689 RSUs; Holding Co. Reorg

iRhythm Holdings, Inc.'s Chief Technology Officer, Lawrence Brian Lee, was granted 6,689 Restricted Stock Units following a holding company reorganization.

Summary

• Lawrence Brian Lee, Chief Technology Officer of iRhythm Holdings, Inc., acquired 6,689 Restricted Stock Units (RSUs) on February 25, 2026.
• Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
• The RSUs will vest 25% on March 1, 2027, and 25% on each subsequent one-year anniversary, contingent on continued service.
• Following this transaction, Mr. Lee beneficially owns 21,168 shares of Common Stock.
• A holding company reorganization occurred on January 12, 2026, where iRhythm Holdings, Inc. became the successor issuer to iRhythm Technologies, Inc., with all outstanding shares and equity awards converting on a one-for-one basis.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive signal, primarily due to the retention and incentive aspect of the RSU grant for a key executive, coupled with a non-dilutive corporate reorganization.

Positives

• The grant of 6,689 Restricted Stock Units to the Chief Technology Officer serves as an incentive for long-term retention and aligns management interests with shareholder value.
• The holding company reorganization was a one-for-one conversion, indicating no dilution or change in proportionate interests for security holders.

Negatives

• The RSU grant is not an immediate cash transaction for the officer, as the shares vest over time.
• Vesting is contingent on continued service, meaning the officer must remain employed to realize the full benefit.

Risks

• The value of the RSUs is subject to the future market price of iRhythm Holdings, Inc. common stock.
• The vesting schedule requires continued employment, which could be a risk for the officer if employment ceases.

Future Outlook

The RSU grant includes a future vesting schedule, with 25% vesting on March 1, 2027, and annually thereafter, contingent on the reporting person's continued service.

Industry Context

StockSavvy.ai notes that equity grants, particularly Restricted Stock Units, are a standard practice in the technology and healthcare sectors to attract, retain, and incentivize key executives. The holding company reorganization is a structural change that often aims for operational efficiencies or legal/tax benefits, and the one-for-one conversion indicates a non-dilutive transition for existing shareholders.

Comparison to Industry Standards

• The grant of RSUs to a Chief Technology Officer is a common compensation practice, comparable to similar grants seen at companies like Medtronic or Abbott Laboratories, which use equity to align executive incentives with long-term company performance.
• The vesting schedule of 25% annually over four years is a standard industry practice for executive equity awards, similar to those observed at many publicly traded tech and medical device companies.
• The holding company reorganization, with a one-for-one share conversion, is a typical non-dilutive corporate restructuring often undertaken for strategic or operational reasons, mirroring similar reorganizations by companies seeking to optimize their corporate structure.

Corporate Governance

Stakeholder Impact

• Shareholders: The RSU grant aligns the Chief Technology Officer's long-term interests with shareholder value. The holding company reorganization had no immediate impact on proportionate ownership.
• Employees: The RSU grant demonstrates the company's commitment to executive compensation and retention, which can positively influence overall employee morale and perception of stability.

Next Steps

• 25% of the granted RSUs will vest on March 1, 2027, subject to continued service.
• Subsequent 25% portions of the RSUs will vest on each one-year anniversary thereafter.

Key Dates

Recommendation

This Form 4 reports a routine equity grant to a key executive and a non-dilutive corporate reorganization. While the RSU grant is a positive for executive retention, it does not present new information that would fundamentally alter the investment thesis for iRhythm Holdings, Inc. Therefore, a "hold" recommendation is appropriate as this filing alone does not warrant a change in investment position.

Keywords

iRhythm Holdings, IRTC, Restricted Stock Units, RSU, Insider Trading, Form 4, Equity Grant, Chief Technology Officer, Lawrence Brian Lee, Corporate Reorganization